%0 Journal Article
%T Modifications of Nanobubble Therapy for Cancer Treatment.
%A Terlikowska KM
%A Dobrzycka B
%A Terlikowski SJ
%J Int J Mol Sci
%V 25
%N 13
%D 2024 Jul 2
%M 39000401
%F 6.208
%R 10.3390/ijms25137292
%X Cancer development is related to genetic mutations in primary cells, where 5-10% of all cancers are derived from acquired genetic defects, most of which are a consequence of the environment and lifestyle. As it turns out, over half of cancer deaths are due to the generation of drug resistance. The local delivery of chemotherapeutic drugs may reduce their toxicity by increasing their therapeutic dose at targeted sites and by decreasing the plasma levels of circulating drugs. Nanobubbles have attracted much attention as an effective drug distribution system due to their non-invasiveness and targetability. This review aims to present the characteristics of nanobubble systems and their efficacy within the biomedical field with special emphasis on cancer treatment. In vivo and in vitro studies on cancer confirm nanobubbles' ability and good blood capillary perfusion; however, there is a need to define their safety and side effects in clinical trials.